Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29701 - 29725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	METTL7A	25840	upregulated	decitabine results in increased expression of METTL7A mRNA	12q13.12	A20985
Decitabine	Approved Investigational	MGMT	4255	upregulated	decitabine results in increased expression of MGMT mRNA	10q26.3	A21994 A21995 A21963
Decitabine	Approved Investigational	MIA	8190	upregulated	decitabine results in increased expression of MIA mRNA	19q13.2	A21919
Decitabine	Approved Investigational	MIR122	406906	upregulated	decitabine results in increased expression of MIR122 mRNA	18q21.31	A21965
Decitabine	Approved Investigational	MIR145	406937	upregulated	decitabine results in increased expression of MIR145 mRNA	5q32	A21965
Decitabine	Approved Investigational	MIR182	406958	upregulated	decitabine results in increased expression of MIR182 mRNA	7q32.2	A21965
Decitabine	Approved Investigational	MIR198	406975	upregulated	decitabine results in increased expression of MIR198 mRNA	3q13.33	A21965
Decitabine	Approved Investigational	MIR34B	407041	upregulated	decitabine results in increased expression of MIR34B mRNA	11q23.1	A21324
Decitabine	Approved Investigational	MIR99A	407055	upregulated	decitabine results in increased expression of MIR99A mRNA	21q21.1	A21965
Decitabine	Approved Investigational	MITF	4286	downregulated	decitabine results in decreased expression of MITF mRNA	3p13	A21930
Decitabine	Approved Investigational	MLF1	4291	upregulated	decitabine results in increased expression of MLF1 mRNA	3q25.32	A21919
Decitabine	Approved Investigational	MLH1	4292	upregulated	decitabine results in increased expression of MLH1 mRNA	3p22.2	A21996 A21944 A21997 A21181 A21998
Decitabine	Approved Investigational	MLH3	27030	upregulated	decitabine results in increased expression of MLH3 mRNA	14q24.3	A21181
Decitabine	Approved Investigational	MMP13	4322	upregulated	[decitabine results in increased expression of LEP mRNA] which results in increased expression of MMP13 mRNA	11q22.2	A21989
Decitabine	Approved Investigational	MORC3	23515	upregulated	decitabine results in increased expression of MORC3 mRNA	21q22.12	A20985
Decitabine	Approved Investigational	MRPS18A	55168	upregulated	decitabine results in increased expression of MRPS18A mRNA	6p21.1	A21917
Decitabine	Approved Investigational	MRPS28	28957	downregulated	decitabine results in decreased expression of MRPS28 mRNA	8q21.13	A20985
Decitabine	Approved Investigational	MS4A3	932	upregulated	decitabine results in increased expression of MS4A3 mRNA	11q12.1	A20985
Decitabine	Approved Investigational	MSH2	4436	upregulated	decitabine results in increased expression of MSH2 mRNA	2p21-p16.3	A21996 A21181
Decitabine	Approved Investigational	MSH4	4438	upregulated	decitabine results in increased expression of MSH4 mRNA	1p31.1	A21181
Decitabine	Approved Investigational	MSH6	2956	upregulated	decitabine results in increased expression of MSH6 mRNA	2p16.3	A21181
Decitabine	Approved Investigational	MSI1	4440	downregulated	decitabine results in decreased expression of MSI1 mRNA	12q24.31	A21913
Decitabine	Approved Investigational	MSMO1	6307	downregulated	decitabine results in decreased expression of MSMO1 mRNA	4q32.3	A20985
Decitabine	Approved Investigational	MSX1	4487	upregulated	decitabine results in increased expression of MSX1 mRNA	4p16.2	A21919
Decitabine	Approved Investigational	MT1M	4499	upregulated	decitabine results in increased expression of MT1M mRNA	16q13	A21915

Displaying entries 29701 - 29725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability